Here’s what you need to know:
1. PRA Health Sciences will serve as Takeda Pharmaceutical’s primary strategic partner, managing clinical studies at all stages of development.
2. PRA Health Sciences will also provide Takeda Pharmaceutical with regulatory, pharmacovigilance and other operational services.
3. Takeda Pharmaceutical expects that about 300 of its employees will transition to PRA Health Sciences, which has offices throughout the United States and Europe. Discussion regarding employees in Japan is ongoing.
More articles on gastroenterology and endoscopy:
Stanford University, twoXAR collaborate on liver cancer treatment: 3 notes
AGA hosts advocacy day to encourage MACRA oversight: 3 notes
Dr. Milena Bogunovic receives $100k award for IBD research: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.